Most-Read Print Managed Healthcare Executive® Articles of 2021

Article

Many of the most-read articles from the print issues of Managed Healthcare Executive® focused on the cost of therapies.

The Price Tags on the COVID-19 Vaccines

Governments are the only buyers so far, and the amounts they are paying varies.

Read more

The Pandemic Pause: When Cancer Care Was Put on Hold

Screening and some care have been canceled or deferred. Will more illness and deaths result?

Read more

Generic Drug Price Tags: Too High. And Too Low. Competition Can Help Create an In-Between.

Low prices and some gaming of regulations can drive out competitors and create monopolies that allow generic makers to jack up their prices. Experience has shown that it often takes multiple generics to achieve the promised-for downward pressure on prices.

Read more

The Rise in Formulary Exclusions

PBMs say exclusions are important for negotiating lower prices on behalf of health plans and members. Some payer and provider groups say they interfere with patient access to medicines.

Read more

How ‘White Bagging’ Affects Patients, Physicians and 340B Funding

Having specialty pharmacies fill prescriptions may lower costs, but critics of the practice see safety issues and other drawbacks.

Read more

Recent Videos
1 Kol is featured in this series
Why consumer price transparency for medication is so important
1 Kol is featured in this series
1 Kol is featured in this series
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.